Current Investment
Family Allergy & Asthma
Prairie Capital Fund VI
| Location | Louisville, KY |
| Transaction Type | Growth Buyout with Founder and Management |
| Investment Date | March 2018 |
| Business | Provider of allergy, asthma, and immunology diagnosis and treatment |
| Industry | Healthcare |
Investment Rationale
- Partnership with founders, physicians and management
- Attractive market trends
- Scalable platform with multiple growth opportunities
- Attractive economic profile
- Proven organic growth strategy
Value Add
- Human Capital
- Sales & Marketing
- Technology
- Infrastructure
- Add-on Acquisitions
TEAM:
After shepherding the growth of Family Allergy & Asthma over 35 years it was important to me to partner with a private equity firm that would allow us to continue to grow, but still maintain the quality and patient focused service we strive for. Meeting the Prairie Capital team, especially Sean McNally and Tony Danielak, was like looking in the mirror in their commitment to “doing the right thing” in their partnership with us. We have not been disappointed.
Prairie Capital stood out from other investment firms by committing to a deep analysis of our industry, which allowed us to hit the ground running. They also understand the cycle of business is not always a straight line up, and I appreciate that we work together on tangible solutions to support growth and also to ensure our success for many years.